Blueblood Ventures Ltd
₹ 11.1
4.93%
29 May 2023
About
Incorporated in 2007, Blueblood Ventures
Ltd provides investment and trading in the financial market[1]
Key Points
- Market Cap ₹ 3.32 Cr.
- Current Price ₹ 11.1
- High / Low ₹ /
- Stock P/E 111
- Book Value ₹ 10.0
- Dividend Yield 0.00 %
- ROCE 0.05 %
- ROE 1.01 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.11 times its book value
Cons
- Company has a low return on equity of 0.68% over last 3 years.
- Contingent liabilities of Rs.9.35 Cr.
- Company might be capitalizing the interest cost
- Company has high debtors of 6,464 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Finance Other Financial Services
Loading peers table ...
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.11 | 0.72 | 2.73 | 59.82 | 0.73 | 0.53 | -0.32 | 0.68 | 0.20 | 0.54 | 0.50 | 0.79 | |
| 0.30 | -10.13 | -1.70 | 55.30 | 0.90 | 3.41 | 0.34 | 0.66 | 0.15 | 0.50 | 0.68 | 1.04 | |
| Operating Profit | 2.81 | 10.85 | 4.43 | 4.52 | -0.17 | -2.88 | -0.66 | 0.02 | 0.05 | 0.04 | -0.18 | -0.25 |
| OPM % | 90.35% | 1,506.94% | 162.27% | 7.56% | -23.29% | -543.40% | -143.48% | 2.94% | 25.00% | 7.41% | -36.00% | -31.65% |
| 0.02 | 0.00 | 0.00 | 0.00 | 0.02 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 0.31 | |
| Interest | 2.68 | 10.63 | 4.11 | 3.30 | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 |
| Depreciation | 0.03 | 0.04 | 0.03 | 0.81 | 0.02 | 0.01 | 0.01 | 0.00 | 0.04 | 0.03 | 0.02 | 0.01 |
| Profit before tax | 0.12 | 0.18 | 0.29 | 0.41 | -0.21 | -2.84 | -0.67 | 0.02 | 0.01 | 0.01 | 0.01 | 0.05 |
| Tax % | 25.00% | 27.78% | 31.03% | 24.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -200.00% | 0.00% | 20.00% |
| 0.09 | 0.12 | 0.20 | 0.30 | -0.21 | -2.85 | -0.66 | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 | |
| EPS in Rs | 1.80 | 0.40 | 0.67 | 1.00 | -0.70 | -9.50 | -2.20 | 0.07 | 0.07 | 0.07 | 0.03 | 0.10 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | % |
| 3 Years: | 58% |
| TTM: | 58% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| TTM: | 200% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | 4% |
| 3 Years: | 0% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.53 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Reserves | 7.49 | 12.10 | 12.26 | 12.56 | 3.30 | 0.46 | -0.21 | -0.19 | -0.17 | -0.04 | -0.04 | 0.00 |
| 37.15 | 100.20 | 141.87 | 137.31 | 94.25 | 94.04 | 94.00 | 94.00 | 94.00 | 94.12 | 96.93 | 94.51 | |
| 17.61 | 22.28 | 1.05 | 1.87 | 1.47 | 1.67 | 1.14 | 0.29 | 0.36 | 0.31 | 0.36 | 1.68 | |
| Total Liabilities | 62.78 | 137.58 | 158.18 | 154.74 | 102.02 | 99.17 | 97.93 | 97.10 | 97.19 | 97.39 | 100.25 | 99.19 |
| 0.12 | 0.08 | 0.07 | 0.05 | 0.03 | 0.02 | 0.01 | 0.02 | 0.08 | 0.06 | 0.04 | 0.03 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.13 | 5.79 | 5.83 | 81.63 | 72.77 | 70.27 | 70.57 | 65.27 | 41.79 | 13.08 | 12.30 |
| 62.66 | 137.37 | 152.32 | 148.86 | 20.36 | 26.38 | 27.65 | 26.51 | 31.84 | 55.54 | 87.13 | 86.86 | |
| Total Assets | 62.78 | 137.58 | 158.18 | 154.74 | 102.02 | 99.17 | 97.93 | 97.10 | 97.19 | 97.39 | 100.25 | 99.19 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -33.70 | -59.78 | -5.00 | 130.27 | -11.44 | -5.91 | -0.89 | -1.36 | -0.66 | -7.09 | -3.21 | 5.91 | |
| 0.59 | 0.01 | -5.53 | 0.08 | 49.21 | 6.16 | 0.85 | 1.36 | 0.71 | 7.09 | 3.35 | -5.90 | |
| 28.68 | 59.38 | 10.44 | -130.39 | -37.76 | -0.21 | 0.00 | 0.00 | 0.00 | 0.00 | -0.08 | 0.00 | |
| Net Cash Flow | -4.43 | -0.39 | -0.08 | -0.04 | 0.01 | 0.04 | -0.04 | 0.00 | 0.05 | 0.00 | 0.06 | 0.01 |
| Free Cash Flow | -33.76 | -59.78 | -5.02 | 130.25 | -11.44 | -5.91 | -0.89 | -1.37 | -0.76 | -7.10 | -3.21 | 5.91 |
| CFO/OP | -1,199% | -550% | -109% | 2,884% | 6,729% | 200% | 135% | -6,800% | -1,320% | -17,725% | 1,783% | -2,364% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1.17 | 0.00 | 0.00 | 0.00 | 0.00 | 1,225.85 | -2,041.72 | 960.81 | 12,154.50 | 10,233.52 | 15,527.10 | 6,463.73 |
| Inventory Days | 3.84 | 498.37 | 52.55 | 660.48 | 129.78 | 1,095.00 | 499.47 | |||||
| Days Payable | 2.69 | 126.35 | 86.63 | 121.67 | 113.56 | 101.39 | 57.63 | |||||
| Cash Conversion Cycle | 1.17 | 0.00 | 0.00 | 1.14 | 372.02 | 1,191.76 | -1,502.91 | 977.03 | 12,154.50 | 11,227.13 | 15,968.94 | 6,463.73 |
| Working Capital Days | 5,221.50 | 58,258.06 | 16,592.12 | -13.67 | 0.00 | 833.30 | 2,064.53 | 901.76 | 12,099.75 | 10,395.74 | 15,695.00 | 5,770.70 |
| ROCE % | 9.51% | 13.47% | 3.23% | 2.39% | -0.13% | -2.85% | -0.69% | 0.02% | 0.01% | 0.01% | 0.10% | 0.05% |
Insights
In beta| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Inventory (Stock-in-trade) INR Lakhs |
|
||||||||
| Non-current Investments INR Lakhs |
|||||||||
| Number of Employees Count |
|||||||||
| Number of Shareholders Count |
|||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Meeting Updates
27 May - Blueblood approved FY26 audited standalone results on 27 May 2026; profit Rs 3.26 lakh, unmodified audit opinion.
-
Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For The Board Has Decided To Approve Standalone Annual Audited Financial Results For The Financial Year 2025-2026 Along With Auditors Report Thereon
27 May - Board approved FY26 standalone audited results on 27 May 2026; auditor gave unmodified opinion.
- Closure of Trading Window 15 May
-
Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For :-To Approve Audited Standalone Financials Results Of The Company For The Half And Financial Year Ended 31 St March,2026.
15 May - Board meeting on 27 May 2026 to approve audited standalone results for half year and year ended 31 March 2026.
-
Declaration Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares Andtakeovers) Regulation, 2011.
8 Apr - Promoters and PAC confirmed nil pledged or encumbered shares as of 31 March 2026.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Business Overview:[1]
BBL is in the business of equity investment and trading in equity, derivatives, commodities, futures & options, venture capital funding, and other financial products.